Stay Connected

NETNPA April Meeting April 17th at Cafe Lola, JC

Cafe Lola Bistro
1805 North Roan Street
Johnson City, TN 37601

Thursday, April 17, 2025 at 6:00pm ET - 8:00pm ET
Add this event to your calendar

1805 North Roan Street, Johnson City, TN 37601

Info

Topic

TREAT CHRONIC HEPATITIS C IN PEOPLE WHO INJECT DRUGS

Attachments
Additional Information

Welcome back NETNPA for our April meeting!

For those who haven't attended a meeting, please note that we are welcoming and open to seeing new faces and hope you join us!  While our announcement usually says 6-9pm, that is not the case entirely so we will recap how our meetings go so that you know what to expect.  :)

NETNPA's reservation time for the event is 6pm, typically people arrive between 5:45pm and 6pm to get settled and chat etc.
Between 6pm and 6:30pm we order our meals, get settled and network.  If we have a business meeting or announcements for NETNPA those are done before 6:30pm.  Typically we want to have orders placed prior to 6:30pm so the speaker can start while the kitchen is doing their magic.

Speaker starts around 6:30pm.  Depending on the content, the speaker usually lasts +/- 30 minutes   Food is served usually during the presentation (at least that's our hope) or shortly after (this is all dependent upon the kitchen).

Usually most content from our presenter is done by 7:15pm and we are left to finish eating, mingle, and enjoy the rest of our evening.  While our announcements say 6-9pm, that is not a requirement or how long the event actuallys lasts.  Usually the 9pm is just to indicate that is when we need to be leaving the restaurant.

Hope this clarifies for those of you who have been on the fence about checking us out.   Hope to see you there!

NETNPA April Meeting

Thursday, April 17, 2025 6:00 PM  

Cafe Lola
1805 North Roan Street
Johnson City, Tennessee

TREAT CHRONIC HEPATITIS C IN PEOPLE WHO INJECT DRUGS

CHAKRADHAR REDDY, MD Assistant Professor of Medicine, Division of Gastroenterology Quillen College of Medicine - East Tennessee State University 

SPONSORED BY: INDICATION EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg) is indicated for the treatment of adults with chronic hepatitis C virus (HCV) genotype 1-6 infection without cirrhosis or with compensated cirrhosis.

Gilead does not provide or pay for alcohol at Speaker Programs. Gilead policy and the PhRMA Code on Interactions with Health Care Professionals limit attendance at this promotional educational program to healthcare professionals. Accordingly, attendance by guests who are non–healthcare professionals is not appropriate and cannot be accommodated.

Interested in attending this event?

Enter your email address below to register for this event.
If you do not have an account, create your account.